The Effect of Aromatherapy Applied to the Patients in the Urodynamic Procedure on Anxiety and Serum Cortisol Levels
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Anxiety
- Sponsor
- Mersin University
- Enrollment
- 98
- Locations
- 1
- Primary Endpoint
- Anxiety evaluated using the State Anxiety Scale
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
This randomized controlled study is planned to determine the effect of aromatherapy applied to patients in the urodynamic procedure on patients' anxiety and serum cortisol levels.
This study assumes that lavender inhalation in aromatherapy has positive effects on physiological parameters such as blood pressure, heart rate, respiratory rate, serum cortisol level, as well as reducing stress and anxiety.
Detailed Description
98 patients in each group will be included in the study (Aromatherapy group=49; Control group=49). In addition to the routine treatment and care practices of the unit, aromatherapy will be applied to the patients included in the study group. Aromatherapy application will be applied to all patients by the same researcher. Aromatherapy application will be started 5 minutes before the urodynamic procedure after the patient is taken to the urodynamics room and lavender essential oil will be used with a diffuser until the end of the procedure. Routine treatment and care interventions will be applied to the patients included in the control group during the procedure.
Investigators
Elife Kettas Dolek
Urology Polyclinic Responsible Nurse
Mersin University
Eligibility Criteria
Inclusion Criteria
- •Those who signed the 'Informed Voluntary Consent Form' to participate in the research,
- •18 years and older,
- •Conscious, oriented and cooperative,
- •Able to communicate
- •Urodynamic procedure applied,
- •No problem in sense of smell,
- •No chronic respiratory disease (lung cancer, chronic obstructive pulmonary disease, asthma, chronic bronchitis, etc.),
- •No history of dermatitis against cosmetic odor,
- •Patients without a known history of allergy to the essential oil used
Exclusion Criteria
- •Those who did not sign the "Informed Consent Form" to participate in the research,
- •Under 18 years of age,
- •Unconscious, without orientation and cooperation,
- •Unable to communicate,
- •Urodynamic procedure is not applied.
- •Having problems with the sense of smell,
- •Having chronic respiratory disease (lung cancer, chronic obstructive pulmonary disease, asthma, chronic bronchitis, etc.),
- •Having a history of dermatitis against cosmetic odor,
- •Having a trait anxiety scale score of 60 and above,
- •Patients with a known history of allergy to the essential oil used
Outcomes
Primary Outcomes
Anxiety evaluated using the State Anxiety Scale
Time Frame: Change from Baseline (before implementation) and within 5 minutes after procedure
Scores ranging from 20 to 80 points are obtained in the scale. In the total score obtained from the scale in scoring the scale, 0-19 points indicate the absence of anxiety, 20-39 points indicate mild anxiety, 40-59 points indicate moderate anxiety, and 60-79 points indicate severe anxiety level. Higher state anxiety scores indicate that anxiety level is also high
Secondary Outcomes
- Change systolic and diastolic blood pressure(Change from Baseline (before implementation) and within 5 minutes after procedure)
- Change serum cortisol level(Change from Baseline (before implementation) and within 5 minutes after procedure)
- Change heart rate(Change from Baseline (before implementation) and within 5 minutes after procedure)
- Change respiratory rate(Change from Baseline (before implementation) and within 5 minutes after procedure)
- Change peripheral oxygen saturation(Change from Baseline (before implementation) and within 5 minutes after procedure)